2026-19004Notice

Novo Nordisk Bails on Subcutaneous Drug Delivery Consortium

Published Date: 9/16/2026

Notice

Summary

The Subcutaneous Drug Development & Delivery Consortium, Inc. announced that Novo Nordisk from Denmark has left their group. This change affects members working together on drug research but doesn’t change the group's goals or other members. The group keeps welcoming new members and will keep updating the government about any changes.

No Economic Impacts Identified for this Document

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
9/16/2026

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Antitrust Division
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register